Lesaffre

Lesaffre operates globally as a leader in industrial biotechnology with a strong focus on the development and commercialization of yeast, bacteria, probiotics, prebiotics, nutritional yeasts, enzymes and other active ingredients derived from microbial fermentation. The company supplies these to the baking industry as well as to human health/nutrition markets. Through its subsidiary Gnosis by Lesaffre—formed after acquiring Gnosis Advanced Biotech—the group has expanded into pharmaceutical-grade actives for nutraceuticals/pharma. Clinical results are not typically published since most products are food/nutritional/ingredient grade rather than prescription therapeutics.